Free Trial
NASDAQ:ZYBT

Zhengye Biotechnology (ZYBT) Stock Price, News & Analysis

Zhengye Biotechnology logo
$5.21 -0.48 (-8.44%)
As of 08/8/2025 03:59 PM Eastern

About Zhengye Biotechnology Stock (NASDAQ:ZYBT)

Key Stats

Today's Range
$5.21
$5.70
50-Day Range
$5.16
$9.30
52-Week Range
$3.50
$14.30
Volume
11,771 shs
Average Volume
28,992 shs
Market Capitalization
$245.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZYBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zhengye Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

ZYBT Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Zhengye Biotechnology Holding Ltd
See More Headlines

ZYBT Stock Analysis - Frequently Asked Questions

Zhengye Biotechnology's stock was trading at $4.86 at the beginning of the year. Since then, ZYBT stock has increased by 7.2% and is now trading at $5.21.

Zhengye Biotechnology (ZYBT) raised $6 million in an initial public offering on Tuesday, January 7th 2025. The company issued 1,500,000 shares at a price of $4.00 per share. Kingswood Capital Partners acted as the underwriter for the IPO.

Zhengye Biotechnology's lock-up period expired on Monday, July 7th. Zhengye Biotechnology had issued 1,500,000 shares in its IPO on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.

Top institutional investors of Zhengye Biotechnology include Geode Capital Management LLC (0.06%).

Shares of ZYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ZYBT
Previous Symbol
NASDAQ:ZYBT
CIK
1975641
Fax
N/A
Employees
278
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.31
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$25.53 million
Price / Sales
9.63
Cash Flow
$0.09 per share
Price / Cash Flow
55.22
Book Value
$1.02 per share
Price / Book
5.11

Miscellaneous

Outstanding Shares
47,170,000
Free Float
N/A
Market Cap
$245.76 million
Optionable
N/A
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ZYBT) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners